The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.

Candida, a type of fungus, can spread throughout the body via the bloodstream, leading to organ damage and sepsis. Recently, ...

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration ...

Some patients with highly drug-resistant tuberculosis could benefit from a shorter treatment with fewer drugs, while others ...

The National Pharmaceutical Pricing Authority (NPPA) has revised the prices of 71 essential drug formulations, encompassing ...

Novartis' Coartem Baby wins Swiss approval as the first malaria drug for newborns under 5 kg, offering safer dosing and ...

Research shows promising results for a weekly injectable Parkinson's treatment that maintains consistent medication levels, ...

Candida auris is a dangerous fungal pathogen that has become a global health concern. It spreads easily in health care settings and can cause life-threatening infections, especially in patients with ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as ...